Kamunting Street Capital Management’s Medtronic MDT Stock Holding History

Kamunting Street Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,500	Closed	-$661K	–	36
2023 Q2	$661K	Buy	+7,500	New	+$646K	0.65%	23
2021 Q2	–	Sell	-7,290	Closed	-$861K	–	104
2021 Q1	$861K	Buy	+7,290	New	+$854K	0.34%	55

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Kamunting Street Capital Management's MDT Position: Q3 2023 in Review

Kamunting Street Capital Management sold out of Medtronic (MDT) in Q3 2023, closing a stake of 7,500 shares — an estimated $661K sold.

Kamunting Street Capital Management first reported a position in MDT in Q1 2021 and held it in 2 quarters. The position peaked at $861K in Q1 2021. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

Kamunting Street Capital Management reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
Kamunting Street Capital Management sold 7,500 Medtronic shares in Q3 2023, an estimated $661K.
Kamunting Street Capital Management first reported a position in Medtronic in Q1 2021 and held it in 2 quarters.
Kamunting Street Capital Management's Medtronic position peaked at $861K in Q1 2021.
1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Kamunting Street Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.